Zepbund: A Breakthrough Medication for Weight Management
Introduction Zepbund (tirzepatide) is a prescription medication developed by Eli Lilly and Company, designed for chronic weight management in adults. Approved by the U.S. Food and Drug Administration (FDA) in 2023, Zepbund is a dual-acting drug that mimics two key hormones to help regulate appetite, improve metabolism, and support significant weight loss. It is primarily…